| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| XmAb-819 | XmAb-819 | Phase 1 Clinical | Xencor Inc | Carcinoma, Renal Cell; Kidney Neoplasms | Details |
| JNJ-89862175 | JNJ-89862175 | Phase 1 Clinical | Janssen Research & Development Llc | Solid tumours | Details |
| ALY-301 | ALY-301; GTX-B001 | Phase 1 Clinical | Alys Pharmaceuticals Inc | Chronic Urticaria; Symptomatic Dermographism; Urticaria | Details |
| JNJ-87890387 | JNJ-87890387 | Phase 1 Clinical | Janssen Research & Development Llc | Neoplasms; Solid tumours | Details |